Skip Nav Destination
Issues
Introduction
Introduction to the Second World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy): Dilemmas in clinical practice
Diabetes Care November 2009, Vol.32, S149-S150. doi:https://doi.org/10.2337/dc09-S300
Diabetes Progression, Prevention, and Treatment
Progression / Prevention
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S157-S163. doi:https://doi.org/10.2337/dc09-S302
Viewpoints on the Way to a Consensus Session: Where does insulin resistance start? The liver
Diabetes Care November 2009, Vol.32, S164-S167. doi:https://doi.org/10.2337/dc09-S303
Viewpoints on the Way to the Consensus Session: Where does insulin resistance start? The adipose tissue
Diabetes Care November 2009, Vol.32, S168-S173. doi:https://doi.org/10.2337/dc09-S304
Where Does Insulin Resistance Start?: The brain
Diabetes Care November 2009, Vol.32, S174-S177. doi:https://doi.org/10.2337/dc09-S305
Goals of Treatment for Type 2 Diabetes: β-Cell preservation for glycemic control
Piero Marchetti, MD, PHD; Roberto Lupi, BS; Silvia Del Guerra, BS; Marco Bugliani, PHD; Valentina D'Aleo, BS; Margherita Occhipinti, MD; Ugo Boggi, MD; Lorella Marselli, MD; Matilde Masini, MD
Diabetes Care November 2009, Vol.32, S178-S183. doi:https://doi.org/10.2337/dc09-S306
Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes: Pro pharmacologic therapy
Diabetes Care November 2009, Vol.32, S184-S188. doi:https://doi.org/10.2337/dc09-S307
Nonpharmacologic Therapy and Exercise in the Prevention of Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S189-S193. doi:https://doi.org/10.2337/dc09-S308
Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S194-S198. doi:https://doi.org/10.2337/dc09-S309
Target for Glycemic Control: Concentrating on glucose
Diabetes Care November 2009, Vol.32, S199-S204. doi:https://doi.org/10.2337/dc09-S310
Self-Monitoring of Blood Glucose as Part of the Integral Care of Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S205-S210. doi:https://doi.org/10.2337/dc09-S312
Telemedical Artificial Pancreas: PARIS (Páncreas Artificial Telemédico Inteligente) research project
Diabetes Care November 2009, Vol.32, S211-S216. doi:https://doi.org/10.2337/dc09-S313
Treatment
Changing the Treatment Paradigm for Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S217-S222. doi:https://doi.org/10.2337/dc09-S314
Incretin-Based Therapies: Viewpoints on the way to consensus
Diabetes Care November 2009, Vol.32, S223-S231. doi:https://doi.org/10.2337/dc09-S315
Antioxidant Anti-Inflammatory Treatment in Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S232-S236. doi:https://doi.org/10.2337/dc09-S316
Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration
Diabetes Care November 2009, Vol.32, S237-S245. doi:https://doi.org/10.2337/dc09-S355
β-Cell Protection and Therapy for Latent Autoimmune Diabetes in Adults
Diabetes Care November 2009, Vol.32, S246-S252. doi:https://doi.org/10.2337/dc09-S317
Insulin Therapy for Type 2 Diabetes
Diabetes Care November 2009, Vol.32, S253-S259. doi:https://doi.org/10.2337/dc09-S318
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents: Basal or prandial insulin? The APOLLO trial and beyond
Reinhard G. Bretzel, MD, PHD; Michael Eckhard, MD; Wolfgang Landgraf, PHD; David R. Owens, MD, FRCP; Thomas Linn, MD, PHD
Diabetes Care November 2009, Vol.32, S260-S265. doi:https://doi.org/10.2337/dc09-S319
Early Insulin Treatment in Type 2 Diabetes: What are the pros?
Diabetes Care November 2009, Vol.32, S266-S269. doi:https://doi.org/10.2337/dc09-S320
Early Insulin Use in Type 2 Diabetes: What are the cons?
Diabetes Care November 2009, Vol.32, S270-S274. doi:https://doi.org/10.2337/dc09-S321
Hypertension and Diabetes Debates
How to Define Prehypertension in Diabetes/Metabolic Syndrome
Diabetes Care November 2009, Vol.32, S275-S279. doi:https://doi.org/10.2337/dc09-S323
Should We Treat Prehypertension in Diabetes?: What are the cons?
Diabetes Care November 2009, Vol.32, S280-S283. doi:https://doi.org/10.2337/dc09-S324
Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?
Diabetes Care November 2009, Vol.32, S284-S289. doi:https://doi.org/10.2337/dc09-S325
Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
Diabetes Care November 2009, Vol.32, S290-S293. doi:https://doi.org/10.2337/dc09-S329
Hypertension and Diabetes: What are the pros to treating early surrogates?
Diabetes Care November 2009, Vol.32, S294-S297. doi:https://doi.org/10.2337/dc09-S356
Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
Diabetes Care November 2009, Vol.32, S298-S304. doi:https://doi.org/10.2337/dc09-S326
Should White-Coat Hypertension in Diabetes Be Treated? Pro
Giuseppe Mancia, MD; Roberto Sega, MD; Michele Bombelli, MD; Fosca Quarti-Trevano, PHD, MD; Rita Facchetti, PHD; Guido Grassi, MD
Diabetes Care November 2009, Vol.32, S305-S309. doi:https://doi.org/10.2337/dc09-S327
White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
Diabetes Care November 2009, Vol.32, S310-S313. doi:https://doi.org/10.2337/dc09-S328
Diabetes and Cardiovascular Disease
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Daniele Versari, MD; Elena Daghini, MD; Agostino Virdis, MD; Lorenzo Ghiadoni, MD, PHD; Stefano Taddei, MD
Diabetes Care November 2009, Vol.32, S314-S321. doi:https://doi.org/10.2337/dc09-S330
Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines
Diabetes Care November 2009, Vol.32, S322-S325. doi:https://doi.org/10.2337/dc09-S331
The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice
Diabetes Care November 2009, Vol.32, S326-S330. doi:https://doi.org/10.2337/dc09-S332
Is Hyperglycemia a Causal Factor in Cardiovascular Disease?: Does proving this relationship really matter? Yes
Diabetes Care November 2009, Vol.32, S331-S333. doi:https://doi.org/10.2337/dc09-S333
Glucose Control and Cardiovascular Disease: Is it important? No
Diabetes Care November 2009, Vol.32, S334-S336. doi:https://doi.org/10.2337/dc09-S334
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
Diabetes Care November 2009, Vol.32, S337-S341. doi:https://doi.org/10.2337/dc09-S335
Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes
Cristina Bianchi, MD; Roberto Miccoli, MD; Giuseppe Daniele, MD; Giuseppe Penno, MD; Stefano Del Prato, MD
Diabetes Care November 2009, Vol.32, S342-S348. doi:https://doi.org/10.2337/dc09-S336
Shifting the Disease Management Paradigm From Glucose: What are the pros?
Diabetes Care November 2009, Vol.32, S349-S352. doi:https://doi.org/10.2337/dc09-S337
Shifting the Disease Management Paradigm From Glucose: What are the cons?
Diabetes Care November 2009, Vol.32, S353-S356. doi:https://doi.org/10.2337/dc09-S338
A Summary of the ADVANCE Trial
Diabetes Care November 2009, Vol.32, S357-S361. doi:https://doi.org/10.2337/dc09-S339
Obesity and Lipids
Adipocytokines and Insulin Resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin
Diabetes Care November 2009, Vol.32, S362-S367. doi:https://doi.org/10.2337/dc09-S340
Diabetes Surgery: A New Approach to an Old Disease
Diabetes Care November 2009, Vol.32, S368-S372. doi:https://doi.org/10.2337/dc09-S341
Triglycerides and HDL Cholesterol: Stars or second leads in diabetes?
Diabetes Care November 2009, Vol.32, S373-S377. doi:https://doi.org/10.2337/dc09-S343
Should All Diabetic Patients Be Treated With a Statin?
Diabetes Care November 2009, Vol.32, S378-S383. doi:https://doi.org/10.2337/dc09-S344
American Diabetes Association Indications for Statins in Diabetes: Is there evidence?
Diabetes Care November 2009, Vol.32, S384-S391. doi:https://doi.org/10.2337/dc09-S345
Fat or Fit: What Is More Important?
Diabetes Care November 2009, Vol.32, S392-S397. doi:https://doi.org/10.2337/dc09-S346
Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf!
Diabetes Care November 2009, Vol.32, S398-S402. doi:https://doi.org/10.2337/dc09-S347
Obesity in the Elderly Diabetic Patient: Is weight loss beneficial? No
Diabetes Care November 2009, Vol.32, S403-S409. doi:https://doi.org/10.2337/dc09-S348
Diagnosis and Treatment of Microvascular Disease
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
Diabetes Care November 2009, Vol.32, S410-S413. doi:https://doi.org/10.2337/dc09-S349
Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
Diabetes Care November 2009, Vol.32, S414-S419. doi:https://doi.org/10.2337/dc09-S350
Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?
Diabetes Care November 2009, Vol.32, S420-S422. doi:https://doi.org/10.2337/dc09-S351
Smoking
Smoking Cessation: It Is Never Too Late
Diabetes Care November 2009, Vol.32, S423-S425. doi:https://doi.org/10.2337/dc09-S352
Why Won't Our Patients Stop Smoking?: The power of nicotine addiction
Diabetes Care November 2009, Vol.32, S426-S428. doi:https://doi.org/10.2337/dc09-S353
Smoking Amplifies Cardiovascular Risk in Patients With Hypertension and Diabetes
Diabetes Care November 2009, Vol.32, S429-S431. doi:https://doi.org/10.2337/dc09-S354
